Make the next claim worth making.

A weak baseline can make an ordinary improvement look impressive. The existing approach deserves to be described fairly: who performs the task, which sources they use, how they check it and what happens when information conflicts.

Agree the outcome before examining a result. A pharmacy group may value dependable follow-through; a medicines committee may need a review that survives professional challenge. The comparison should reflect that purpose and include the effort introduced by a different workflow. Study design and necessary approvals are agreed before evaluation begins.

A second track concerns the work after agreement. A decision can be recorded while training, a handover or a supply question remains unresolved. Counting approved proposals alone would miss the operational issue.

We want to examine how a defined change moves through a real process: ownership, completion, delays, queries, rework and support. The comparison needs records that suit the task. It should distinguish an action completed in a tool from a change observed in practice, and account for other events that could explain the result.

Professional judgement is part of the product question. Can a reviewer recognise a missing source or an unsupported inference? Does the presentation encourage challenge? Does uncertainty help someone identify the next question, or become another detail to ignore?

Planned human-factors work would examine error detection, over-reliance, understanding of uncertainty, workload and accessibility. Different experience levels and working conditions may affect the result. The purpose is to learn which design choices support careful use and where the interface needs to change before the approach can progress.

A study should be capable of challenging the proposition. The most useful finding may identify a narrower task, a different user group or an approach that adds too much burden. Those results help concentrate development where it can offer greater value.

The NICE evidence standards framework offers relevant context for planning digital-health evidence. The appropriate methods still depend on intended use and the particular question. A clear study should leave participants with an interpretable finding and a justified next decision. These proposed tracks provide a basis for agreeing that work with suitable evaluation partners.

DMS Commissioner Value Scan is a proposed review of discharge-medicines referral, action and completion gaps. A suitable evaluation would ask whether the resulting account helps commissioners and pharmacy teams identify a worthwhile next action.

A pharmacy-service activation direction would examine readiness, completed consultations, accepted claims and the value remaining after delivery costs. The comparison needs to show whether a service’s apparent momentum is sustained in the actual work.

A hospital outpatient options comparison would examine expected benefit, delivery effort and the conditions needed for an option to work. Hospital and provider economics would be assessed separately, with a defined setting and an agreed comparison before an evaluation proceeds.